| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | $189.4M+8.3% | $175.0M+38.3% | $126.5M+59.1% | $79.5M+40.2% | $56.8M |
| Selling, general and administrative | $72.2M+20.7% | $59.8M+18.3% | $50.6M+30.4% | $38.8M+67.1% | $23.2M |
| Total operating expenses | $261.6M+11.4% | $234.8M+32.6% | $177.1M+49.7% | $118.3M+48.0% | $80.0M |
| Loss from operations | -$261.6M-11.4% | -$234.8M-32.6% | -$177.1M-49.7% | -$118.3M-48.0% | -$80.0M |
| Research and development incentives | $1.8M-7.7% | $1.9M-34.1% | $2.9M-8.1% | $3.2M+12.9% | $2.8M |
| Investment income | $21.1M-9.6% | $23.4M+133.4% | $10.0M+2465.6% | $390K-57.4% | $916K |
| Interest expense on finance lease liability | -$2.1M+2.1% | -$2.2M+1.5% | -$2.2M+1.2% | -$2.2M+0.8% | -$2.2M |
| Interest expense on debt obligations | -$5.8M-28.4% | -$4.5M-129.1% | -$2.0M | $0+100.0% | -$818K |
| Other (expense) income | -$202K-126.2% | $771K+113.6% | -$5.7M-436.0% | -$1.1M-59.2% | -$665K |
| Total other income, net | $14.8M-23.7% | $19.4M+528.6% | $3.1M+1009.4% | $278K+130.4% | -$915K |
| Loss before income taxes | -$246.8M-14.6% | -$215.4M-23.8% | -$174.0M-47.4% | -$118.0M | — |
| Income tax provision | $468K+14.7% | $408K+41.7% | $288K | $0 | — |
| Net loss | -$247.3M-14.6% | -$215.8M-23.8% | -$174.3M-47.7% | -$118.0M-46.0% | -$80.9M |
| Net loss per common share, basic (in dollars per share) | -$3.07+5.2% | -$3.24-8.4% | -$2.99-32.3% | -$2.26-29.1% | -$1.75 |
| Net loss per common share, diluted (in dollars per share) | -$3.07+5.2% | -$3.24-8.4% | -$2.99-32.3% | -$2.26-29.1% | -$1.75 |
| Weighted average common shares outstanding, basic (in shares) | 80.56B+21.0% | 66.57B+14.4% | 58.21B+111393.0% | 52.2M-99.9% | 46.25B |
| Weighted average common shares outstanding, diluted (in shares) | 80.56B+21.0% | 66.57B+14.4% | 58.21B+111393.0% | 52.2M-99.9% | 46.25B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.